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ABSTRACT
Is a follow up endoscopic retrograde cholangiography
procedure necessary for removal of biliary stent?
Shashank Ponugoti
Follow up endoscopic retrograde cholangiopancreatography (ERCP) procedure is
routinely performed to remove biliary stents. Simply removing the stents is
feasible with upper endoscopy (EGD), which costs less, is technically less
challenging, is likely to be more comfortable for the patient, and is safer from a
sedation perspective. But therapeutic interventions requiring ERCP may
preclude this option. The aim of this study was to analyze the utility of follow up
ERCP for biliary stent removal and to determine if follow up ERCP procedure is
necessary in all patients. The study population comprised 284 adults who had
undergone ERCP for stent placement and stent removal at the WVU Endoscopy
Center between January 2005 and December 2011. Detailed information on each
patient was obtained from medical records. Patients were categorized into five
groups - those with bile leak alone (N=31), choledocholithiasis (N=127), benign
stricture (N=77), malignant stricture (N=44) and bile leak with stone or stricture
(N=5). On follow up ERCP, only 16% of patients in the bile leak group required
therapy. In contrast, 90% of patients with choledocholithiasis, 82% of patients
with benign stricture and 100% of patients in the remaining two groups required
therapy that could only be accomplished with follow up ERCP. The two most
common employed therapies in follow up ERCPs were stone or sludge removal
(57%) and stent replacement (35%). Conclusions: In this retrospective study
spanning 7 years, only 16% of patients with uncomplicated bile leak required a
follow up ERCP for stent removal, whereas ERCP related interventions were
needed at follow-up in 82-100% of patients with other conditions. Larger
prospective studies are needed to confirm these findings and to determine if EGD
might serve as a viable and cost effective alternative to ERCP in cases of
uncomplicated bile leak.
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IS A FOLLOW UP ENDOSCOPIC RETROGRADE
CHOLANGIOGRAPHY PROCEDURE NECESSARY
FOR REMOVAL OF BILIARY STENT?
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INTRODUCTION:
Endoscopic retrograde cholangiopancreatography (ERCP) is the preferred
procedure for purposes of diagnosis and therapy in pathological conditions of
biliary and pancreatic origin. In particular, ERCP is generally performed to treat
obstructive jaundice due to common bile and/or pancreatic duct obstruction.
While ERCP has been used to treat obstructions of varying etiologies, stone
removal using ERCP is most commonly performed in patients with
choledocholithiasis1. Usually, a biliary stent is deployed after cleaning the
common bile duct (CBD) either by evacuating stones or by dilatation of the
stricture. The stent is placed temporarily and should be removed after a certain
period of time with either repeat ERCP or side viewing EGD. Bile leak is a
complication secondary to iatrogenic trauma during cholecystectomy that occurs
in 2% of cases2 or blunt trauma to the abdomen. The common modality of
treatment for bile leak is to use ERCP for placing a biliary stent to cover the
leak3,4. Although the optimal length of time for stent removal is not known, the
stent is usually removed within 3-8 weeks after ensuring the complete healing of
the bile leak4. Benign and malignant strictures of the biliary tree are other frequent
complications that require ERCP for cholangiography, dilatation, cytology
brushings and stent placement1. The standard practice at our institution was to
repeat the ERCP in 6-8 weeks following the initial procedure to assess

2

improvement, determine potential complications, and perform any required
procedures, including stent removal or exchange.
While ERCP is widely used and may be necessary in certain settings, there
are also challenges associated with ERCP procedures. For example, expertise in
ERCP requires extensive training and experience in both diagnostic and
therapeutic ERCP procedures 5. The endoscopist must be prepared and competent
to perform any indicated therapeutic intervention(s) at the time of diagnostic
ERCP procedure6. ERCP procedures are associated with significantly greater
morbidity and mortality than EGD even when performed by highly skilled
clinicians1,7. In addition, the complication rate for ERCP is higher than that of all
other commonly performed endoscopies8. Complications are both procedure- and
anesthesia-related

9,10

. The cost of the ERCP is also much higher than those of

regular endoscopy 11,12.
Biliary stents can be removed either by ERCP or by side viewing
EGD13,14. However, there have been very few studies comparing the effectiveness
of EGD to ERCP in removal of biliary stents, and currently specific
recommendations for use of EGD vs ERCP are lacking. Simply removing the
stents is feasible with EGD, a procedure which is less costly, technically less
challenging, more comfortable for the patient and safer from a sedation
perspective than ERCP. In this retrospective chart review study, we assessed the
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utility of follow up ERCP to help determine if EGD can serve as a cost effective
alternative to ERCP for stent removal. We conducted this study to investigate the
role of ERCP in the management of patients with biliary stents; in addition, we
conducted an in depth evaluation to determine if follow up ERCP procedure is
necessary for biliary stent removal and to identify the conditions for which follow
up cholangiography may be absolutely required at the time of stent removal.

METHODS:
Potential subjects for the research study were identified from the West
Virginia integrated data repository (IDR), a centralized electronic database that
pools clinical information from sources throughout the state. All data are
deidentified to protect patient confidentiality. The database was queried to obtain
a list of all adults above eighteen years of age who had undergone ERCP for stent
placement and stent removal (CPT codes 43268 and 43269) at the WVU
Endoscopy Center at Ruby Memorial Hospital between January 2005 and
December 2011. All charts were evaluated in detail and pertinent information
gathered, including that regarding demographics, diagnosis based on imaging and
ERCP findings, indications for the procedure, procedural findings and type of
intervention used. Patients who underwent biliary stent placement at an outside
facility, or pancreatic stent placement or exchange, as well as patients lost to
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follow up were excluded from the analysis. This study was approved by the
Institutional Review Board (Tracking # H-20344) at West Virginia University,
Morgantown, WV.

Data abstraction
Medical records of the subjects were accessed by the principal
investigator. Pertinent data on each patient were entered into a Microsoft excel
spreadsheet

using

a

standardized

template,

including

information

on:

demographics, initial diagnosis, indication for the procedure, findings and
interventions performed and date of the ERCP procedure, as well as follow-up
ERCP findings and interventions. The time interval between the ERCP was also
measured. Data were pooled based on the diagnosis and specific interventions
performed.

Definitions
For each patient, age was defined as the age at the date of initial ERCP
procedure. Diagnosis of the condition was determined based on findings from
imaging, the initial ERCP and pathology reports. Patients were categorized into
five groups based on the following presenting diagnoses- bile leak,
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choledocholithiasis, benign stricture, malignant stricture and bile leak with stone
or stricture. Bile leak generally occurs as a complication of the cholecystectomy
or in response to blunt trauma to the abdomen. Spontaneous bile leaks are very
rare.

Statistical analysis
All data analyses were performed using statistical software R (ref).
Descriptive statistical analyses were performed to characterize the study
population, including mean with standard deviation (or median with range) for
continuous variables and proportions or contingency tables for categorical
variables. The variables of interest include patient diagnoses and complications,
time intervals between the initial and follow-up ERCP, and procedures performed.
A consort diagram was used to describe the schematic design of the study
population. A bar-plot was used to display the ERCP findings among various
diagnoses groups. Chi Square test or Fishers Exact tests were used to determine
between group differences in categorical variables; and t-tests were used to
investigate between-group difference in continuous variables. Statistical analyses
were considered significant if p-value was less than 0.05.
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Choledocholithiasis
n=127

Benign Stricture
n=77

Analyzed
(Na = 284)

Malignant Stricture
n=44

Bile Leak
n=31

Total Charts
N=430

Bile leak and
Stone/Strictue
n=5

Excluded
(Ne=146)

Criteria: Immediate
Complications (n=5), Lost for
follow up (n=26), Intial ERCP
done at outside facility (n=37),
Pancreatic stenting(n=78).

Figure 1: Schematic design of the subjects included and excluded in the study
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RESULTS:
A total of 430 patients underwent ERCP procedure for various conditions
during the period between 1 January 2005 and 31 December 2011. Of these
patients, 146 did not meet our inclusion criteria, yielding a final sample of 284
eligible adults (Figure 1). Of the 146 excluded patients, five had complicated
initial ERCP procedure with multiple complications requiring immediate follow
up ERCP; 37 had stent placement in an outside facility; 26 were lost to follow up;
and 78 had pancreatic stent placement and/or exchange.
Subjects were categorized into five diagnostic groups based on findings
from

initial

ERCP

procedure;

these

included

Bile

leak

Choledocholithiasis (N=127), Benign stricture (N=77), Malignant

(N=31),
stricture

(N=44) and Bile leak with Stone or Stricture (N=5). Of the 5 patients in bile leak
with stone or stricture group, four had microlithiasis (including stone/sludge), and
one had stricture of the CBD as secondary findings.
Patient demographics, overall and by group are given in Table 1. Patients
ranged from 15 to 90 years of age with a mean age of 59 (±19) years; 41% were
male. Age varied substantially among groups, with group means ranging from
45.4(±19.34) years in those with simple bile leak to 66.5(±11.7) years in those
with malignant stricture. Average age in the bile leak group was significantly
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lower than that in all other groups (P<0.001). There was no significance between
group differences in gender distribution (P’s> 0.5, Fisher exact test) (Table 1).
All the patients (100%) analyzed had follow-up ERCP for stent removal. Ninety
six percent (272/284) of the patients underwent sphincterotomy during the initial
procedure; in contrast, only 24 patients underwent sphincterotomy during their
follow up ERCP. Of these 24 patients, 9 did not have spinchterotomy performed
during the initial ERCP procedure. The remaining 15 patients underwent an
extension of sphincterotomy.
The most common intervention performed during follow up ERCP was
sludge or stone removal, followed by dilatation and brushings and stent
placement. One patient with bile leak and stricture underwent extension
sphincterotomy during follow up ERCP. None of the patients in the
uncomplicated bile leak group (n=31) had sphincterotomy during follow up
ERCP. The time interval between stent placement and removal/exchange ranged
from 4 to 303 days, with a median time interval of 77 days. The median time
interval was significantly lower in the malignant stricture group than in the
remaining groups (p=<0.007; two-sample t-test). All patients with malignant
stricture 44 (100%) required stent exchanges with metallic stent in follow up
ERCP.

9

Table 1: Demographics of the subjects by diagnoses group

Total (N)

Male, n(%)

Age range

Mean age (SD)

Bile Leak
Stone
Stricture(benign)
BL/S/S
Malignant Stricture
Benign Pathology

31
127
77
5
44
240

16 (52)
51 (40)
27 (35)
3 (60)
20 (45)
97 (40)

18-80
15-89
23-90
56-79
45-90
15-90

45.4 (19.34)
59.0 (20.62)
61.0 (17.78)
65.0 (8.98)
66.5 (11.68)
57.7 (19.93)

Total

284

117 (41)

15-90

59.1 (19.11)

Table 1: Demographics: Stone – Choledocholithiasis, BL/S/S – Bile leak with Stone or stricture,
Benign pathology (BP) = Total – Malignant stricture. SD- Standard deviation. Age group was
significantly lower in Bile leak group compared to all other groups (p<0.001). No significant
group differences in gender distribution (p>0.05).
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All patients in Bile leak group with Stone or Stricture had abnormal pathology
during follow up ERCP, requiring intervention only possible using ERCP. One
patient had benign CBD stricture with further dilatation, brushings and stent
exchange performed during follow up ERCP; after 64 days, a third ERCP was
needed for stent removal after ensuring adequate patency of CBD. The remaining
four patients had stone/sludge along with bile leak at the time of initial ERCP.
Although the sludge/stone was extracted during initial ERCP, all four required
intervention with sludge extraction during follow up ERCP.
Of the 31 patients in Bile leak group, 26 (84%) had normal ERCP and completely
healed bile leak, requiring no further intervention at follow-up. The remaining
five patients had abnormal findings at follow-up ERCP, including one with
persistent bile leak at a 34 day follow up ERCP; this patient was successfully
treated with placement of a stent, which was removed at 6 weeks following ERCP
confirmation of complete healing. The remaining four patients had sludge
extracted during the second ERCP procedure, although initial ERCP procedure
notes did not indicate stone or sludge extraction. All cases of bile leak were due to
complications of cholecystectomy.
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Table 2: Findings and Interventions performed during initial and follow up ERCP
Procedures.

BL

CDL

BS

BL/S/S

BP

MS

TOTAL

Total, N

31

127

77

5

240

44

284

Median Time
interval between
ERCP’s – in days
(Range)

97
(27-190)

77
(7-193)

64
(5-252)

87
(76-145)

80
(5-252)

37
(4-303)

77
(4-303)

26(84)

13(10)

14(18)

0(0)

53(22)

0(0)

53(19)

4(13)

108(85)

54(70)

4(80)

170(71)

11(25)

181(64)

0(0)

12(9)

7(9)

1(20)

20(8)

4(9)

24(8)

1(3)

23(18)

31(40)

1(20)

56(23)

44(100)

100(35)

Normal result on
repeat ERCP n
(%)
Dilatation/
Brushings/Balloon
extraction
n (%)
Sphincterotomy
n (%)

Stent Placement
n (%)

Table 2: Procedural therapies performed in different groups in follow up ERCP. BL – Bile leak, CDLCholedocholithiasis and Microlithiasis, BS- Benign stricture, BL/S/S – Bile leak with Stone or Stricture, MSMalignant stricture, BP- Benign Pathology = BL +CDL+BS+ BL/S/S, SD – Standard deviation
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As shown in table 3, findings at follow-up ERCP were abnormal in a
significantly lower percentage of patients with uncomplicated bile leak(16%
(5/31)) than in those with Choledocholithiasis- (90% (114/127)) (p<0.0001),
Benign stricture (82% (63/77)) (p<0.0001), bile leak with stone or stricture (100%
(5/5)) (p 0.0007), or malignant stricture (100% (44/44)) (p<0.0001). Eighty-four
% (26/31) of the patients with uncomplicated bile leak had normal findings on
repeat ERCP, whereas only 10% of the patients with choledocholithiasis and 18%
with benign stricture had normal findings on repeat ERCP. Interestingly, none
(0%) of the patients in malignant obstruction group or Bile leak with Stone or
Stricture group had normal findings on repeat ERCP.
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Table 3: Normal and abnormal findings of follow up ERCP by diagnoses
group and statistical analysis.

Bile Leak
n(%)

Choledocholithiasis
n (%)

Benign
Stricture
n (%)

Bile leak +
Stone/stricture
n (%)

Malignant
Stricture
n (%)

Normal
N = 53

26(84)

13(10)

14(18)

0(0)

0(0)

Abnormal
N= 231

5(16)

114(90)

63(82)

5(100)

44(100)

p-value

ref

<0.0001

<0.0001

0.0007

<0.0001

Table 3: Statistical analysis between normal and abnormal findings, Normal: no leak
or obstruction or strictures in follow up ERCP. Abnormal: either leak or stone or
stricture in follow up ERCP requiring intervention.
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120%
100%
80%
60%
40%
20%

Normal Result on Repeat ERCP
Requiring Stent on Repeat ERCP

0%
Requiring Any Therapy on
Repeat ERCP

Figure 2.
groups.

Bar-plot of follow-up ERCP findings among various diagnoses
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DISCUSSION:
Biliary stent placement is a common endoscopic procedure for various
biliary pathologies by conventional ERCP. ERCP is associated with several life
threatening complications, including those directly related to the procedure

8,15

and those related to anesthesia 10,16. In addition, the cost of ERCP is much higher
than that of regular EGD14,17,18. The procedure is also challenging to perform,
requiring extensive training and experience. Given these drawbacks, we
conducted a study using existing patient data to determine if ERCP is necessary
for stent removal in all patient populations. We performed a retrospective chart
review in all patients who underwent stent removal and compared findings, for 5
patient groups, of initial and follow up ERCP. Our study results suggest that, in
all but patients with simple bile leak, repeat ERCP is likely necessary as a follow
up procedure for stent removal as most will require therapy along with stent
removal, which can be accomplished only with ERCP. However, in patients with
uncomplicated bile leak, use of a regular side viewing EGD would likely be
sufficient to remove the stent in the vast majority of cases.
Complications of ERCP include pancreatitis, hemorrhage, cholangitis,
septicemia 19, perforation and various other complications such as recurrent stone
formation and sphincterotomy stenosis8,20,21. Pancreatitis occurs in 6.7% of
general population and in up to 15–30% of high-risk patients22. Bleeding is seen
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endoscopically in 10-30% of the patients undergoing Sphincterotomy23.
Perforation is reported in less than 1% of the patients undergoing ERCP and
sphincterotomy24-26.
Previous findings regarding need for ERCP during stent removal in
patients with bile leak have been inconsistent, rendering the establishment of
specific recommendations for use of ERCP vs EGD challenging. For example,
Coelho and Baron showed good results for stent removal with EGD in their recent
study of 64 post bile leak patients14. In contrast, Jain et al showed significant
abnormalities requiring ERCP for stent removal in their investigation of 80 bile
leak patients13. This inconsistency in findings may in part reflect differences in
patient populations. However, to our knowledge, no previous studies have
investigated potential variation in outcome and associated need for ERCP at stent
removal in different patient diagnostic groups.
Several studies have reported costs of ERCP procedures to substantially
exceed those of regular endoscopy procedure12,17,18. Likewise, we found similar
cost discrepancies in our analysis of ERCP and EGD billing data from the WVU
Endoscopy center using Medicare/Medicaid reimbursement rates. Costs for ERCP
with stent removal using Code 43269 are $2163.76 vs. $977.13 for an EGD with
stent removal/intervention (coded as 43267), a difference of $1186.63 per
procedure. These figures are consistent with the findings of Coelho et al., who
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showed that approximately $500,000 a year can be saved using EGD rather than
ERCP for stent removal in patients with biliary leak14.
In our study, more than 90% of patients with choledocholithiasis, benign
stricture, malignant stricture and bile leak with stricture or stone required repeat
ERCP. However, in patients with simple bile leak, only 16 % needed intervention
requiring ERCP; of those requiring subsequent therapy, four of them required
sludge removal and the initial ERCP procedure notes failed to mention if there
was any sludge or stone extracted, and in the 5th case, stent removal was likely
performed too soon; the low complication rate in those with simple bile leak
suggests that stent removal using EGD may be a viable and cost-effective
alternative for these patients.
Our study has several limitations. Findings are based on retrospective
data, and miscategorization remains possible. Relative to other groups, sample
size in the bile leak group was relatively small, and thus our findings, while
consistent with previous research, must be interpreted with caution. While we
collected data on a large number of patients undergoing stent placement and
removal using ERCP, we lacked information on outcomes of stent removal using
EGD. Clearly, a larger, prospective study is needed to determine if EGD might be
a cost effective substitute for ERCP in uncomplicated bile leak patients, and
possibly other patient groups. Studies are also needed to identify specific high
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risk patient populations most likely to need follow-up interventions requiring
ERCP in Bile leak group. Our findings strongly suggest that bile leak patients
with sludge, microlithiasis or stricture during initial ERCP procedure will require
follow up ERCP procedure to assess adequate resolution of associated pathology
along with primary pathology. In these patients, complete extraction of the bile
sludge during initial procedure would be beneficial, but would likely still not
preclude using ERCP for stent removal.
CONCLUSION
In this retrospective chart review study of 284 patients undergoing stent
removal, our findings suggest a repeat ERCP for stent removal will be required
for over 90% of patients with a diagnosis of choledocholithiasis, benign stricture,
malignant stricture and complicated bile leak. However, the low complication
rates observed in patients with uncomplicated bile leak suggest that, for these
patients, a regular side viewing EGD may provide a safer and more cost effective
alternative to ERCP. Larger prospective studies should be conducted to clearly
identify the risk factors that indicate the need for ERCP vs a regular EGD in
patients with bile leak and possibly other conditions.
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